Medicare Advantage Newsfeed

The HHS Office of Inspector General released findings showing Medicare Advantage plans are denying prior authorizations for skilled nursing facility (SNF) and long-term inpatient rehab care at unusually high rates, with over 95% of appealed denials ultimately overturned. The report names UnitedHealth, two other major plans, and documents pattern denials that appear designed to delay or discourage access to post-acute care. Congressional lawmakers are calling for 'meaningful penalties' on offending carriers.

This is the most significant regulatory signal on MA denial practices in years. It directly threatens plan economics (SNF/rehab denials drive margin recovery), signals CMS enforcement priority, and creates precedent for increased penalties. Expect Congressional pressure for legislative amendments to strengthen oversight and financial consequences for inappropriate denials.

A federal court ordered CMS to upgrade Clover Health's Medicare Advantage star rating to 4.5 (from a lower level), overturning a CMS methodology challenge. The upgrade applies to Clover's PPO plan covering 97% of its enrolled members and will materially improve its 2027 capitated payments, resulting in higher Star Bonus payments and enrollment incentives. Stock jumped 10–14% on the news.

This is a landmark challenge to CMS's star rating methodology and signals potential vulnerabilities in CMS's rating framework. The decision may open the door to similar challenges from other plans, creating uncertainty in the 2027 and 2028 payment adequacy landscape. For Clover, it substantially improves financial viability and reduces exit risk; for competitors, it complicates rate planning assumptions.

The Congressional Joint Economic Committee released an analysis pegging annual Medicare Advantage overpayments to plans at approximately $7 billion and rising due to risk adjustment system gaming, encounter data inaccuracies, and incomplete compliance audits. The report links overpayments directly to plan profitability and suggests tightened audit frequency and penalties are warranted.

This is explicit Congressional documentation of systemic overpayment — a key focal point for potential rate adjustment, RADV audit intensity increases, or legislative penalties. It will likely prompt CMS to strengthen its encounter data validation and risk adjustment audit protocols, directly impacting plan margins and operational costs.

Following the June 10 CMS rate announcement for 2027, industry analysts confirm an average revenue increase of 2.48% to MA plans—substantially above the initial 0.09% projection. This relief comes after 2026's severe market compression, but experts note plans will continue modest benefit cuts, network curation, and regional exits rather than aggressive expansion. KFF data show MA enrollment growth is slowing (55% of eligible beneficiaries now enrolled).

The upward rate revision stabilizes plan economics and reduces exit urgency, but the 2.48% increase is insufficient to reverse 2026 benefit cuts or restore aggressive supplemental benefit offerings. Plans will remain in 'managing margins under modest headwinds' mode. This affects enrollment velocity, beneficiary switching incentives, and broker compensation structure planning for 2027.

GoHealth, one of the largest independent MA enrollment brokers and a GOCO competitor, filed for Chapter 11 bankruptcy protection on June 8, citing declining commission revenues and structural headwinds in the Medicare Advantage broker market. The company's lenders will assume control; the filing signals severe distress in the retail MA distribution channel amid commission compression and tighter plan margins.

GoHealth's collapse is a canary-in-the-coal-mine signal for the entire independent MA broker ecosystem. It indicates that broker economics have deteriorated below viability for mid-sized players lacking scale or specialized capabilities. Expect further consolidation in MA distribution, margin compression for retail brokers, and potential shift of enrollment responsibility back to plans or toward larger aggregators (eHealth, SelectQuote, Integrity Marketing).

Elevance Health (ELV/Anthem) is under scrutiny from CMS regarding compliance obligations with a late-June regulatory deadline. Reports indicate regulatory uncertainty regarding the company's MA and Medicaid operations. Stock has declined as investors refocus on the compliance overhang.

Regulatory pressure on a Tier 1 payer signals CMS enforcement momentum beyond UnitedHealth and denial practices. Any CMS penalties, operational restrictions, or rate adjustments for Elevance would set precedent for enforcement across the market. This is a key risk factor for investor positioning in the sector.

Fairview Health Services in Minnesota announced it will not accept UnitedHealth Medicare Advantage beneficiaries beginning 2027, citing reimbursement disputes and operational friction. This is one of several recent provider network exits by major systems in response to MA plan contracting practices.

Provider-plan relationship deterioration directly impacts member access and satisfaction, increasing MA plan churn risk and beneficiary complaints. UnitedHealth's market dominance and aggressive contracting posture have made it a focal point for provider disputes. Expect more high-profile network losses for UNH and other large MA plans, driving member exits and regulatory scrutiny.